We need more articles like this to get the word out.


'The Implications of PD-L1 Level Enhancement

By boosting PD-L1 levels, leronlimab is tapping into the immune system's latent power to combat cancer cells more effectively. This development is not just a win for CytoDyn but also for the broader field of cancer therapy, offering hope for previously unresponsive tumors."

https://www.gurufocus.com/news/2859545/cytody...-potential